TAG:
laboratory company
Bi-Coastal Powerhouse Formed by Lab Merger
By Robert Michel | From the Volume VI No. 13 – September 20, 1999 Issue
CEO SUMMARY: Changes to healthcare continue to stimulate responses from independent commercial laboratories. This time it’s a merger of Las Vegas-based Associated Pathologists Laboratories with American Medical Laboratories of Chantilly, Virginia. This combination creates the third-larg…
Finally: Respect for Cytyc As Aetna OKs ThinPrep®
By Robert Michel | From the Volume VI No. 13 – September 20, 1999 Issue
CEO SUMMARY: Here’s an important development in the battle to get the healthcare community to accept new technology for the preparation of Pap smears. Aetna/U.S. Healthcare announced that it would cover the monolayer preparation tests offered by Cytyc and AutoCyte. Aetna’s decision ma…
Ten Myths of Lab Management That Led the Clinical Lab Industry Astray
By Robert Michel | From the Volume VI No. 11 – August 9, 1999 Issue
Part One of a Special Series CEO SUMMARY: One of our most popular series ever was the “13 Perilous Parallels” of laboratory management. This four-part story appeared in 1996 and chronicled similar management strategies used by various national laboratories during the…
Quest Holds Off on SBCL, Leaves the Door Open
By Robert Michel | From the Volume VI No. 10 – July 19, 1999 Issue
CEO SUMMARY: It’s a cryptic situation as of press time. Quest Diagnostics issued a public statement on July 1 stating that its acquisition of SmithKline Beecham Clinical Laboratories would not close on July 2, as expected. Since that date, there’s been no further comment on the situat…
Choosing a Eulogy for SBCL
By R. Lewis Dark | From the Volume VI No. 9 – June 28, 1999 Issue
What is an appropriate eulogy for SmithKline Beecham Clinical Laboratories (SBCL), soon to be acquired by …
Quest and SBCL Expect Merger Date Of July 2
By Robert Michel | From the Volume VI No. 9 – June 28, 1999 Issue
CEO SUMMARY: After months of waiting and planning, executives at Quest Diagnostics Incorporated believe that July 2, 1999 will be the date when their acquisition of SmithKline Beecham Clinical Laboratories becomes official. During the month of July, expect a flurry of activity at Quest Di…
Palo Alto Needle Reuse Episode Widens in Scope
By Robert Michel | From the Volume VI No. 8 – June 7, 1999 Issue
CEO SUMMARY: As many as 15,000 people have been offered free blood testing because they may have been drawn by this phlebotomist since 1994. Regulatory action, private lawsuits, and media coverage are subjecting laboratories to unwelcome, even unwarranted, scrutiny. As the ramifications o…
Sales & Marketing Is Critical To Success Of Labs & Pathologists
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
CEO SUMMARY: Careful study of the most successful lab oratories operating today reveals a common characteristic: the effective use of sale s and marketing methods to boost specimen volume, revenue, and operating profits. This is true whether it’s a hospital lab outreach program, a comme…
Quest to Pay $1.27 Billion To Buy SB’s Lab Division
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
CEO SUMMARY: Consolidation is the story of the clinical laboratory industry during the 1990s. The decade will close out with the granddaddy laboratory consolidation of them all! When Quest Diagnostics Incorporated completes its acquisition of SmithKline Beecham Clinical Laboratories later…
Integrating Quest & SBCL Presents a Big Challenge
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
CEO SUMMARY: Will lessons learned during the commercial lab industry’s consolidation frenzy be learned and applied in the Quest-SBCL merger? History has a way of repeating itself. But Quest Diagnostics’ CEO has a different plan. He also has a tool not utilized by lab executives earlie…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized